Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 28, 2013CancerOpen Access

MicroRNA‐222 and MicroRNA‐146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJames C. LeeUniversity of California, San FranciscoJZJing ZhaoNorthwestern UniversityRCRoderick Clifton‐BlighThe University of Sydney

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lee et al. (2013) studied this question.

synapsesocial.com/papers/6a6d4e66660549caf2c2dc6ehttps://doi.org/10.1002/cncr.28254
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer2010 · 697 citations
  2. 2miRNA Expression in a Human Papillary Thyroid Carcinoma Cell Line Varies with Invasiveness2010 · 28 citations
  3. 3Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma2012 · 132 citations
  4. 4A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration2012 · 157 citations
  5. 5miR-146b is Highly Expressed in Adult Papillary Thyroid Carcinomas with High Risk Features Including Extrathyroidal Invasion and the BRAF V600E Mutation2010 · 221 citations